Dertzbaugh M T, Macrina F L
Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond 23298-0678.
Infect Immun. 1990 Jun;58(6):1509-13. doi: 10.1128/iai.58.6.1509-1513.1990.
An antigenic 15-amino-acid peptide sequence (gtfB.1) from the glucosyltransferase B enzyme of the cariogenic bacterium Streptococcus mutans GS-5 was identified previously from the genetic fusion of this sequence to the B subunit of cholera toxin. The resulting chimeric protein was used to raise antiserum in rabbits. This antiserum was shown to recognize the native glucosyltransferase enzyme and to inhibit its activity. The antiserum inhibited the synthesis of water-soluble glucan by approximately 40% and the synthesis of water-insoluble glucan by greater than 90%. The antiserum was shown to partially inhibit fructosyltransferase activity as well. The ability of this antipeptide antiserum to inhibit several enzymes from S. mutans suggests that these enzymes share an epitope related to enzymatic activity.
先前已从致龋菌变形链球菌GS-5的葡糖基转移酶B的基因融合中鉴定出一种抗原性15氨基酸肽序列(gtfB.1),该序列与霍乱毒素的B亚基融合。所得嵌合蛋白用于在兔中制备抗血清。该抗血清显示能识别天然葡糖基转移酶并抑制其活性。该抗血清能使水溶性葡聚糖的合成抑制约40%,水不溶性葡聚糖的合成抑制超过90%。该抗血清也显示能部分抑制果糖基转移酶活性。这种抗肽抗血清抑制变形链球菌几种酶的能力表明,这些酶共享一个与酶活性相关的表位。